sanofi glp-1 SOLIQUA® 100/33 (insulin glargine & lixisenatide) injection 100 Units/mL & 33 mcg/mL and natural appetite control. Sanofi nabs long-sought FDA approval

J Trace Elem Med Biol

The Times took time to get around to that In the first 136 words of The New York Times story, we learned that experts were impressedthe results are a huge step forward in weight loss management and relief of orthopedic painand a tremendous result. But not a word about all of those adverse effects until you read through 460 words - if you read that far - four times deeper into the story than in the STAT story

Moreover, transgenic tobacco leaves constitutively over-expressing PHGPX gene from L

Monster needed to differentiate itself while building brand loyalty among a young, adventurous audience

Most patients barely notice them

doi: 10.1136/gutjnl-2012-302779